FDA Approves Copiktra

09.25.2018

BOSTON–(BUSINESS WIRE)–Sep. 24, 2018– Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve […]